Interaction of meloxicam with cimetidine, Maalox, or aspirin. Journal of clinical pharmacology. [J Clin Pharmacol] Journal article

Title	Interaction of meloxicam with cimetidine, Maalox, or aspirin.
Author(s)	Busch U, Heinzel G, Narjes H, Nehmiz G
Institution	Department of Pharmacokinetics, Karl Thomae GmbH, Biberach/Riss, Germany.
Source	J Clin Pharmacol 1996 Jan; 36(1):79-84.
MeSH	Administration, Oral Adult Aluminum Hydroxide Antacids Anti-Inflammatory Agents, Non-Steroidal Anti-Ulcer Agents Aspirin Biological Availability Chromatography, High Pressure Liquid Cimetidine Cross-Over Studies Drug Combinations Drug Interactions Histamine H2 Antagonists Humans Magnesium Hydroxide Male Middle Aged Thiazines Thiazoles
Abstract	Meloxicam is a new enol carboxamide nonsteroidal antiinflammatory drug (NSAID). Preclinical studies have indicated that it possesses a high antiinflammatory potency and a low ulcerogenic potency. This open, randomized, crossover study was conducted to examine the effects of aspirin, the antacid Maalox (Rhone-Poulenc Rorer, Cologne, Germany), and cimetidine on the pharmacokinetics and bioavailability of a single oral dose of meloxicam 30 mg in healthy male volunteers. Plasma concentrations of meloxicam were determined and subjected to noncompartmental pharmacokinetic analysis. Meloxicam was well tolerated, and concomitant treatment with cimetidine or Maalox had little or no effect on the plasma concentration-time curves, maximum plasma concentration (Cmax), or the area under the plasma concentration-time curve (AUC0-infinity) of meloxicam. Concurrent treatment with aspirin increased plasma concentrations of meloxicam, increasing Cmax by approximately 25% and AUC0-infinity by 10%. These differences were not considered to be clinically relevant, and no adjustments of meloxicam dose should be required with coadministration of aspirin, Maalox, or cimetidine.
Language	eng
Pub Type(s)	Clinical Trial Journal Article Randomized Controlled Trial
PubMed ID	8932547

Advertise on this site.